Seeking Alpha

Raptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application...

Raptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application for RP103 for the potential treatment of nephropathic cystinosis.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|